The role of the microbiome in cancer development and therapy
Роль микробиома в развитии и терапии рака
2017-05-08
SCID: 54.1/j96ub4n7
Discuss with AI
cancer microbiomecheckpoint immunotherapygnotobiotic mouse modelsmicrobiome dysbiosistumorigenesis
Figures from the paper
Abstract (AI)
Answer questions and earn CME/CNE The human body harbors enormous numbers of microbiota that influence cancer susceptibility, in part through their prodigious metabolic capacity and their profound influence on immune cell function. Microbial pathogens drive tumorigenesis in 15% to 20% of cancer cases. Even larger numbers of malignancies are associated with an altered composition of commensal microbiota (dysbiosis) based on microbiome studies using metagenomic sequencing. Although association studies cannot distinguish whether changes in microbiota are causes or effects of cancer, a causative role is supported by rigorously controlled preclinical studies using gnotobiotic mouse models colonized with one or more specific bacteria. These studies demonstrate that microbiota can alter cancer susceptibility and progression by diverse mechanisms, such as modulating inflammation, inducing DNA damage, and producing metabolites involved in oncogenesis or tumor suppression. Evidence is emerging that microbiota can be manipulated for improving cancer treatment. By incorporating probiotics as adjuvants for checkpoint immunotherapy or by designing small molecules that target microbial enzymes, microbiota can be harnessed to improve cancer care. CA Cancer J Clin 2017;67:326-344. © 2017 American Cancer Society.
Key Findings
1
Dysbiosis is associated with many additional malignancies, although association studies cannot establish whether microbiome changes cause or result from cancer.
2
Gnotobiotic mouse studies support a causal role for microbiota in altering cancer susceptibility and progression.
3
Manipulating microbiota with probiotics or small molecules targeting microbial enzymes may improve cancer treatment, including checkpoint immunotherapy.
4
Microbial pathogens contribute causally to tumorigenesis in approximately 15%–20% of cancer cases.
5
Microbiota influence cancer through inflammation modulation, DNA damage induction, and production of metabolites that promote oncogenesis or tumor suppression.
Research Object
Human microbiota and their interactions with cancer
Research Subject
The influence of microbiota composition and microbial activities on cancer susceptibility, tumorigenesis, progression, and response to therapy
Publication Details
Publication Date
2017-05-08
Journal
Publisher
ISSN
Cited by
698
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest